Results 281 to 290 of about 116,743 (338)

Hidden GPCR structural transitions addressed by multiple walker supervised molecular dynamics (mwSuMD). [PDF]

Elife
Deganutti G, Pipito L, Rujan RM, Weizmann T, Griffin P, Ciancetta A, Moro S, Reynolds CA.   +7 more
europepmc   +1 more source

Idiopathic Arginine Vasopressin Deficiency With Mild and Reversible Hypercalcemia. [PDF]

Ochsner J
Malik A, Goyal A, Gupta R, Bhagat A.
europepmc   +1 more source

Hydrocortisone and arginine vasopressin in post-resuscitation shock: the HYVAPRESS trial. [PDF]

Resusc Plus
Geri G, Lascarrou JB, Levy B, Asfar P, Muller G, Legriel S, Ricôme S, Cour M, Klouche K, Sauneuf B, Quenot JP, Bougouin W, Cariou A, HYVAPRESS investigators.   +13 more
europepmc   +1 more source

Acute Optogenetic Activation of the Subfornical Organ Produces Sympathetically Mediated Increases in Blood Pressure.

Neuroendocrinology
Van Acquoy ML, Nedelkoska T, McMullan S, Burke PGR, Hildreth CM.   +4 more
europepmc   +1 more source

Errors in Text.

JAMA
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Association of Catecholamine Dose, Lactate, and Shock Duration at Vasopressin Initiation With Mortality in Patients With Septic Shock*

Critical Care Medicine, 2021
OBJECTIVES: To determine the association of catecholamine dose, lactate concentration, and timing from shock onset at vasopressin initiation with in-hospital mortality. DESIGN: Retrospective, observational study using segmented and multivariable logistic
G. Sacha, S. Lam, Lu Wang, A. Duggal, Anita J. Reddy, S. Bauer   +5 more
semanticscholar   +1 more source

Vasopressin

Seminars in Respiratory and Critical Care Medicine, 2004
Vasopressin is a hormone that is essential for both osmotic and cardiovascular homeostasis. A deficiency of vasopressin exists in some shock states and replacement of physiological levels of vasopressin can restore vascular tone. Vasopressin is therefore emerging as a rational therapy for vasodilatory shock.
Cheryl L, Holmes, James A, Russell
openaire   +2 more sources

Effect of exogenous vasopressin on vasopressin release

American Journal of Physiology-Endocrinology and Metabolism, 1984
To characterize the influence of extracellular volume status on vasopressin pharmacokinetics, eleven young (aged 19-31 yr) and four old (aged 62-80 yr) subjects received bolus injections of 1 mU/kg Pitressin or synthetic arginine vasopressin following 6 days of sodium depletion (10 meq Na/day) or sodium loading (250 meq Na/day).
G. L. Robertson, P. A. Engel, Kenneth L. Minaker, John W. Rowe   +3 more
openaire   +3 more sources